30 results
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental
DEFA14A
5wsr96h
2 Jun 23
Additional proxy soliciting materials
4:05pm
8-K
EX-1.1
5pmuvsb6 96
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
bp2f objl78i65vg
16 May 23
Other Events
5:21pm
DEF 14A
qmpfoo7yu
21 Apr 22
Definitive proxy
8:00am
10-K
gcqubtl93pourgki
9 Mar 22
Annual report
7:30am
8-K
EX-99.1
n4ockryy5lv9vujrvbb7
9 Mar 22
TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities
7:13am
8-K
EX-99.1
7572ap42r3cym96
10 Nov 21
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
7:02am